河北医科大学学报 ›› 2023, Vol. 44 ›› Issue (5): 562-566,588.doi: 10.3969/j.issn.1007-3205.2023.05.013

• • 上一篇    下一篇

血清miRNA-210、miRNA-223预测新生儿缺血缺氧性脑病预后的临床价值

  

  1. 1.河北省保定市第二中心医院新生儿科,河北 保定 072750;2.河北省保定市第二中心医院儿科,河北 保定 072750

  • 出版日期:2023-05-25 发布日期:2023-05-25
  • 作者简介:赵颖(1985-),女,河北涿州人,河北省保定市第二中心医院主治医师,医学学士,从事新生儿疾病诊治研究。
  • 基金资助:
    保定市科技计划项目(18ZF233)

Clinical value of serum miRNA-210 and miRNA-223 in predicting the prognosis of neonatal hypoxic ischemic encephalopathy

  1. 1.Department of Neonatology, the Second Central Hospital of Baoding City, Hebei Province, 
    Baoding 072750, China; 2.Department of Pediatrics, the Second Central Hospital of 
    Baoding City, Hebei Province, Baoding 072750, China

  • Online:2023-05-25 Published:2023-05-25

摘要: 目的 探讨血清miRNA-210、miRNA-223预测新生儿缺血缺氧性脑病预后的临床价值。
方法 选取新生儿缺血缺氧性脑病患儿124例作为观察组,根据新生儿磁共振成像(magnetic resonance imaging,MRI)病情严重程度将其分为轻度组51例、中度组40例、重度组33例,并选取同期60例健康新生儿作为对照组。然后根据患儿出生后28 d内预后情况将患儿分为生存组81例与死亡组43例。采用实时荧光定量聚合酶链式反应(polymerasechainreaction,PCR)检测血清微小RNA-210(mircoRNA-210,miRNA-210)、微小RNA-223(mircoRNA-223,miRNA-210)水平,分析其水平对预测新生儿缺血缺氧性脑病预后的临床价值。
结果 新生儿缺血缺氧性脑病患儿血清miRNA-210、miRNA-223表达量均高于健康对照组(P<0.05),重度组患儿血清miRNA-210、miRNA-223水平高于轻度组和中度组患儿,差异有统计学意义(P<0.05)。单因素分析结果显示,开始治疗日龄、Apgar评分、缺血缺氧性脑病病情严重程度、白细胞介素6、C反应蛋白、血清miRNA-210表达量、血清miRNA-223表达量与新生儿缺血缺氧性脑病患儿预后有关(P<0.05)。多因素分析结果显示,开始治疗日龄高于2.25 d(OR=3.554,95%CI:1.300~9.713)、病情严重程度未重度(OR=4.450,95%CI:2.189~9.048)、血清miRNA-210升高(OR=3.117,95%CI:1.598~6.082)、血清miRNA-223升高(OR=3.384,95%CI:1.790~6.398)是影响新生儿缺血缺氧性脑病患儿预后的独立危险因素(P<0.05)。ROC曲线分析结果显示,血清miRNA-210最佳分界值为1.71时,预测新生儿缺血缺氧性脑病患儿预后的曲线下面积为0.76,此时敏感度为78.62%,特异度为76.35%;miRNA-223最佳分界值为1.48时,预测新生儿缺血缺氧性脑病患儿预后的曲线下面积为0.79,此时敏感度为81.54%,特异度为76.18%;二者联合检测预测新生儿缺血缺氧性脑病患儿预后的曲线下面积为0.85,此时敏感度为86.73%,特异度为75.49%。
结论 新生儿缺血缺氧性脑病患儿miRNA-210、miRNA-223升高,其水平升高与患儿病情严重程度及预后密切相关,miRNA-210、miRNA-223升高对预测新生儿缺血缺氧性脑病患儿预后具有较好预测价值。


关键词: 缺血缺氧, 脑; RNA;预后

Abstract: Objective To explore the clinical value of serum miRNA-210 and miRNA-223 in predicting the prognosis of neonatal hypoxic-ischemic encephalopathy (NHIE). 
Methods A total of 124 newborns with NHIE were collected as the observation group. According to the severity of neonatal MRI, they were divided into the mild group (n=51), the moderate group (n=40) and the severe group (n=33), and 60 healthy newborns during the same period were selected as the control group. According to the prognosis within 28 days after birth, the children were divided into a survival group (n=81) and a death group (n=43). Serum microRNA-210 (miRNA-210) and microRNA-223 (miRNA-223) levels were detected by real-time fluorescence quantitative PCR, and the clinical value of its level in predicting the prognosis of NHIE was analyzed. 
Results The expression levels of serum miRNA-210 and miRNA-223 in newborns with NHIE were higher than those in the healthy control group (P<0.05). and higher in the severe group than in the mild group and the moderate group, and the difference between the groups was statistically significant (P<0.05). Univariate analysis showed that age at the initation of treatment, Apgar score, severity of hypoxic ischemic encephalopathy, interleukin-6, C-reactive protein, serum miRNA-210 expression, and serum miRNA-223 expression were associated with the prognosis of newborns with NHIE (P<0.05). The results of multivariate analysis showed that the age at the initation of treatment that was higher than 2.25 days (OR=3.554, 95%CI: 1.300-9.713), non-severity based on the severity of the disease (OR=4.450, 95%CI: 2.189-9.048), and an increase in serum miRNA-210 (OR=3.117, 95%CI: 1.598-6.082) and an increase in serum miRNA-223 (OR=3.384, 95%CI: 1.790-6.398) were independent risk factors affecting the prognosis of newborns with NHIE (P<0.05). Receiver operating characteristic (ROC) curve analysis showed that when the optimal cut-off value of serum miRNA-210 was 1.71, the area under the ROC curve (AUC) for predicting the prognosis of NHIE was 0.76, the sensitivity was 78.62%, and the specificity was 76.35%. When the optimal cutoff value of miRNA-223 was 1.48, the AUC for predicting the prognosis of NHIE was 0.79, the sensitivity was 81.54%, and the specificity was 76.18%. The AUC of the two indicators in combination for the prognosis of newborns with NHIE was 0.85, with a sensitivity of 86.73% and a specificity of 75.49%. 
Conclusion miRNA-210 and miRNA-223 are elevated in newborns with NHIE, which are closely related to the severity and prognosis of newborns. Increased miRNA-210 and miRNA-223 have good predictive value in the prognosis of children with NHIE. 


Key words: hypoxia-ischemia, brain; , RNA, prognosis